Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lannett Co. Inc (LCI)

Lannett Co. Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 364,628
  • Shares Outstanding, K 40,335
  • Annual Sales, $ 655,410 K
  • Annual Income, $ -272,110 K
  • 60-Month Beta 2.22
  • Price/Sales 0.55
  • Price/Cash Flow 2.40
  • Price/Book 1.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.27
  • Number of Estimates 3
  • High Estimate 0.29
  • Low Estimate 0.25
  • Prior Year 0.86
  • Growth Rate Est. (year over year) -68.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.71 +6.89%
on 11/12/19
13.12 -29.04%
on 11/04/19
-1.51 (-13.96%)
since 10/14/19
3-Month
5.91 +57.53%
on 08/27/19
15.52 -40.01%
on 09/13/19
+2.83 (+43.67%)
since 08/14/19
52-Week
4.33 +115.01%
on 12/26/18
15.52 -40.01%
on 09/13/19
+3.90 (+72.09%)
since 11/14/18

Most Recent Stories

More News
Lannett Co Inc Falls 13.31% on Heavy Volume: Watch For Potential Rebound

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $9.32 to a high of $10.05. Yesterday, the shares fell 13.3%, which took the trading range below the 3-day low of $9.60...

LCI : 9.31 (+2.99%)
Dermira has the Best Relative Performance in the Pharmaceuticals Industry (DERM , LLY , LCI , BMY , ZTS )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 7.53 (-6.92%)
LLY : 111.39 (-1.24%)
LCI : 9.31 (+2.99%)
Lannett (LCI) Beats Q1 Earnings and Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 4.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

LCI : 9.31 (+2.99%)
Lannett Announces Fiscal 2020 First-Quarter Financial Results

Financial and Business Highlights:

LCI : 9.31 (+2.99%)
Prothena (PRTA) Reports Narrower-than-Expected Loss in Q3

Prothena (PRTA) posts a narrower Q3 loss while sales surpass estimates.

RHHBY : 37.3400 (-0.69%)
CELG : 110.02 (-0.35%)
PRTA : 10.71 (+4.18%)
LCI : 9.31 (+2.99%)
Radius (RDUS) Q3 Earnings Beat Estimates on Tymlos Strength

Radius (RDUS) reports a narrower-than-expected loss and beats sales estimates in the third quarter of 2019 as Tymlos gains traction.

LLY : 111.39 (-1.24%)
AMGN : 218.50 (-0.53%)
RDUS : 23.71 (-1.00%)
LCI : 9.31 (+2.99%)
Mallinckrodt (MNK) Q3 Earnings Beat, Stock Down on Sales Miss

Mallinckrodt (MNK) misses on sales but beats on earnings in the third quarter of 2019.

PTLA : 26.87 (-1.83%)
LCI : 9.31 (+2.99%)
FGEN : 34.98 (+1.16%)
MNK : 2.79 (-4.12%)
Bausch (BHC) Beats on Q3 Earnings & Sales, Raises Guidance

Bausch (BHC) beats on sales and earnings in the third quarter and raises annual guidance.

LCI : 9.31 (+2.99%)
PTLA : 26.87 (-1.83%)
FGEN : 34.98 (+1.16%)
BHC : 27.75 (+1.35%)
Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y

Endo (ENDP) reports better-than-expected results for the third quarter as Xiaflex delivers a strong performance.

LCI : 9.31 (+2.99%)
FGEN : 34.98 (+1.16%)
ENDP : 4.16 (-3.03%)
PTLA : 26.87 (-1.83%)
Lannett (LCI) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Lannett (LCI) closed at $11.88, marking a -1% move from the previous day.

LCI : 9.31 (+2.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft.

See More Share

Trade LCI with:

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

2nd Resistance Point 9.82
1st Resistance Point 9.57
Last Price 9.31
1st Support Level 9.02
2nd Support Level 8.72

See More

52-Week High 15.52
Fibonacci 61.8% 11.25
Fibonacci 50% 9.93
Last Price 9.31
Fibonacci 38.2% 8.60
52-Week Low 4.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar